UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program
About the UNC-Duke Clinical Pharmacology Training Program
The UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program is a collaboration between the UNC Eshelman School of Pharmacy, the UNC Institute for Drug Safety Sciences and the Duke Clinical Research Institute to prepare clinician-scientists to become leaders in clinical pharmacology research.
This two-year program meets the fellowship training expectations set forth by the American Board of Clinical Pharmacology and is a registered member of ABCP. We anticipate that 80 percent of our graduates will obtain board certification in clinical pharmacology.
Clinical pharmacology, in the broadest sense, encompasses drug discovery, clinical development, regulatory issues, therapeutic use and individualization of drug therapy, optimization of drug dosage regimens, an understanding of drug-induced toxicity, and measures to prevent or minimize adverse effects of drugs.
The UNC-Duke Collaborative Clinical Pharmacology Training program, the University of North Carolina at Chapel Hill and Duke University are equal opportunity educational institutions, are committed to the principle of diversity and are particularly interested in receiving applications from a broad spectrum of people, including minorities, protected veterans, and individuals with disabilities.
The UNC-Duke Collaborative Clinical Pharmacology Training Program is committed to providing reasonable accommodations. Individuals with disabilities seeking additional information about services available on the UNC and Duke campuses may visit these sites:
- UNC Accessibility Resources and Services (https://accessibility.unc.edu/)
- UNC Equal Opportunity and Compliance Office, which administers the ADA program for faculty and staff (http://eoc.unc.edu/)
- Duke Disability Management System (http://access.duke.edu/index.php)